IPTLD® a Registered Trademark by Donato Perez Garcia
Paseo de los Heroes # 10999 - 607
Tijuana, B.C. 22010 México
Phone:
From US: 011-52-(664)-686-5473
From US: 011-52-(664)-635-1834
Email: drdonato3@iptldmd.com
Join us at:
Copyright © 1930 – 2010 Donato Perez Garcia
For the historic record, here is the entire first IPT website, just one page. It was put on Tijuana Net for Dr. Donato Perez Garcia in 1996 .
Cancer: Use of Biologic Response Modifiers, insulin hormone, as a neo-adjuvant anticancer drug potentiator in the treatment of some cancers.
Photo 1 : mammogram suggests
presence of infiltrating ductal carcinoma
accompanied by two palpable nodes in
the right axilla. (February 3,1989)
Photo 2: mammogram take after the
completion of a 8 courses of
treatments with the insulin protocol
reveals complete regression of
axillary and breast masses.
(June 15,1989).
Photo 3: Initial X-ray of left arm from a 3 year old girl
diagnosed with Ewing's sarcoma of the bone
(August 17,1970)
Photo 4: Follow-up X-ray of left arm, 8 years post-treatment
(September 1978)
Complete tumor regression has been achieved without surgery or radiotherapy in patients with some types of cancer using insulin as a biological response modifier combined with reduced doses of anticancer drugs. This treatment resulted in marked reduction of dose-related side effects caused by the anticancer drugs.
Administering pharmacological doses of exogenous insulin to patients with some types of cancer and, at the onset of hypoglycemia, follow this with low doses of anticancer drugs. Drug potentiation results from an insulin induced increase in trans-membrane passage allowing for greater intracellular concentration of drug. The technique has been pioneered by the late Dr. Donato Perez Garcia, Sr., his son and grandson- Dr. Donato Perez Garcia y Bellon and Dr. Donato Perez Garcia, working in Mexico. Their initial clinical trials started back in 1948. Dr, SGA, of the Chicago Medical School, North Chicago, Illinois has been following closely these technique, developed by the Dr. Perez, since 1975. He has confirmed the safety and efficacy of the insulin as a neo-adjuvant anticancer drug potentiator in the treatment of some cancer's producing dramatic complete and long-term regression of tumor masses in all subjects without adverse effects and with excellent cosmetic results in the case of breast cancer. Even Dr. M. Fink, from Klinikum Furth in Germany, had good results with the treatment of metastatic cancer, using the technique developed by the Dr. Perez, noticing a 70% decrease in the tumor volume after a 10 day follow-up. (January 22,1992).
Questions:
Email to: drdonato3@iptldmd.com
Dr. Donato Perez Garcia
Paseo de los Herpes # 10999 - 607
Tijuana, B.C. 22010 Mexico
Phone (from US): O11-52-(664)686-5473
[Monday - Friday 9am - 5pm.
BY APPOINTMENT ONLY. ]
Scientific References -Medical Journals-: (l.-)Revista Medica Militar 1938; volume 1, number 2:1-70. ; (2.-)Medical Hypotheses 20(2):199-210, 1986.; (3.-)Res Commun Chem Pathol Pharmacol 63(1):45-52,1989.; (4.-)Medical Hypotheses 29:283-291, i 989.; (5.-)European Journal of Cancer, 26,1262-1263, 1990.
Lectures at Scientific Conventions: (1.-)Forty-second Annual Symposium on Fundamental Cancer Research, The University of Texas,M.D.Anderson Cancer Center, October 24-27,1989.; (2.-)Third International Congress on Neoadjuvant Chemotherapy, Paris, France, February 6-9, 1991.
Historical Materials:(1.-) TIME Magazine article, April 10,1944.